checkAd

     121  0 Kommentare Alzchem and Crearene Develop Treatments for the Dialysis Market - Seite 2

    About Alzchem

    Alzchem is a globally active specialty chemicals company that is one of the market leaders in most of its fields of activity. Alzchem benefits from the three very different global developments climate change, population growth and longer life expectancy in a unique way. Alzchem products can offer attractive solutions for achieving the resulting social goals in a multitude of different applications.

    The company sees interesting growth prospects for itself in the areas of human and animal nutrition and agriculture in particular. As a result of population growth, it is necessary to achieve efficient food production. Pharmaceutical raw materials and creatine products can contribute to a healthy old age as life expectancy increases. Alzchem is facing up to the goal of sustainability arising from climate change in the field of renewable energies and across the entire company. The fields of fine chemicals and metallurgy offer just as great a perspective.

    Alzchem Group AG’s broad product range includes dietary supplements, precursors for corona tests and pharmaceutical raw materials. These products are the company's response to global trends and developments. Alzchem is ideally positioned in this respect and considers itself well prepared for an environmental future and global developments.

    The company employs around 1,630 people at four production sites in Germany and a plant in Sweden, as well as three sales companies in the USA, China and UK. Alzchem generated Group sales of around EUR 422.3 million and EBITDA of around EUR 62.0 million in 2021.



    End of Media Release


    Issuer: Alzchem Group AG
    Key word(s): Health

    31.08.2022 CET/CEST Dissemination of a Press Release, transmitted by DGAP - a service of EQS Group AG.
    The issuer is solely responsible for the content of this announcement.

    The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
    Archive at www.dgap.de


    Language: English
    Company: Alzchem Group AG
    Dr.-Albert-Frank-Str. 32
    83308 Trostberg
    Germany
    Phone: +498621862888
    Fax: +49862186502888
    E-mail: ir@alzchem.com
    Internet: www.alzchem.com
    ISIN: DE000A2YNT30
    WKN: A2YNT3
    Listed: Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Stuttgart
    EQS News ID: 1432203
    Seite 2 von 3


    Diskutieren Sie über die enthaltenen Werte


    EQS Group AG
    0 Follower
    Autor folgen

    Verfasst von EQS Group AG
    Alzchem and Crearene Develop Treatments for the Dialysis Market - Seite 2 DGAP-Media / 31.08.2022 / 14:23 CET/CEST Joint Press Release Alzchem and Crearene Alzchem Group AG and Crearene AG, based in Frauenfeld in Switzerland, have agreed on an exclusive memo of understanding (MOU) for the development and commercialization …

    Schreibe Deinen Kommentar

    Disclaimer